Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies.

MLA

Shamseddine, Achraf, et al. “Innate Immune Signaling Drives Late Cardiac Toxicity Following DNA-Damaging Cancer Therapies.” The Journal of Experimental Medicine, vol. 220, no. 3, Mar. 2023. EBSCOhost, https://doi.org/10.1084/jem.20220809.

APA

Shamseddine, A., Patel, S. H., Chavez, V., Moore, Z. R., Adnan, M., Di Bona, M., Li, J., Dang, C. T., Ramanathan, L. V., Oeffinger, K. C., Liu, J. E., Steingart, R. M., Piersigilli, A., Socci, N. D., Chan, A. T., Yu, A. F., Bakhoum, S. F., & Schmitt, A. M. (2023). Innate immune signaling drives late cardiac toxicity following DNA-damaging cancer therapies. The Journal of Experimental Medicine, 220(3). https://doi.org/10.1084/jem.20220809

Chicago

Shamseddine, Achraf, Suchit H Patel, Valery Chavez, Zachary R Moore, Mutayyaba Adnan, Melody Di Bona, Jun Li, et al. 2023. “Innate Immune Signaling Drives Late Cardiac Toxicity Following DNA-Damaging Cancer Therapies.” The Journal of Experimental Medicine 220 (3). doi:10.1084/jem.20220809.